Clinical Endocannabinoid Deficiency was a theory posited by Dr. Russo back in 2001 in which he theorized that low endocannabinoid levels could be behind a range of chronic conditions such as IBS, fibromyalgia, migraines, and other treatment-resistant syndromes. Dr. Russo suggested that because these conditions are all developed over time, rather than congenitally, and that they could be a result of disturbances to the ECS. This also means there’s a possibility of reversing them.
As we wrap up our deep dive into cannabis and exercise, I can't help but…
With Zoap, Cadillac Rainbow, and Blueberry Caviar. The post Leafly Buzz: 12 hot strains to…
Follow our links to verified aid groups. The post LA’s cannabis community steps up for…
As you might imagine, telling Americans they can't have their guns AND their ganja isn't…
The new ILGM is a veritable treasure trove of expert knowledge that’ll help you find…
edibles, tinctures, beverages, and cannabis oil to name a few. Now, the results of a…